 Serum alpha-L-fucosidase sensitive marker hepatocellular carcinoma Forty-nine liver disease patients chronic persistent hepatitis CPH chronic active hepatitis CAH liver cirrhosis LC primary hepatocellular carcinoma PHC LC PHC associated LC controls serum alpha-L-fucosidase ALF alpha-fetoprotein AFP levels several routine liver injury parameters Tumor diameter hepatic cancer Only ALF AFP patients PHC PHC LC patients patients LC accepted cutoff level ng/ml AFP level false negative tests hand ALF level mumol/hr/ml sensitivity specificity relationship ALF level Child criteria liver injury parameter evident individual values ALF AFP tumor size finding ALF level value early detection PHC follow-up patients PHC